Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Covalon Technologies is a specialized medical device and biotechnology company focused on infection control, therapeutic surface coatings, and advanced wound care. The company leverages its proprietary biopolymer and antimicrobial platforms to develop high-performance products that prevent infections and promote healing in clinical settings. Covalon's core business involves the commercialization of advanced wound dressings, surgical site infection prevention films, and the licensing of its antimicrobial coating technologies to other medical device manufacturers. Headquartered in Canada, the company serves a global market, providing solutions that address critical challenges in vascular access and chronic wound management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cover-All Technologies.